Sequenom (SQNM) Receives Notice That SEC is Investigating April 29 Announcement Regarding SEQureDx Down Syndrom Test
In a Form 8-K, Sequenom (Nasdaq: SQNM) disclosed that on June 29, 2009, it received written notification that the SEC has initiated an investigation relating to our April 29, 2009 announcement regarding it's SEQureDx Down syndrome test. Sequenom said it intends to cooperate fully with the SEC in this matter and that its internal investigation is ongoing.
Related Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
